Reuters logo
Dr Reddy's launches prostate cancer drug in India
December 7, 2012 / 11:36 AM / 5 years ago

Dr Reddy's launches prostate cancer drug in India

MUMBAI, Dec 7 (Reuters) - Dr. Reddy’s Laboratories Ltd , India’s No. 2 drugmaker by sales, said it has launched Pamorelin, a drug to treat prostate cancer, in India.

Dr Reddy’s will import and sell Pamorelin in India through an exclusive marketing deal with Switzerland-based Debiopharm Group, the Indian company said in a statement on Friday. (Reporting by Kaustubh Kulkarni; Editing by Prateek Chatterjee)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below